Wow amazing how the panic sets in when a stock drops a pip or 2....

Wow amazing how the panic sets in when a stock drops a pip or 2. Seriously ANP have said all along that they have planned for this trial and raised for this trial and have again stuck to their timelines and ticked another box. This has nothing to do with the negotiations and ANP have stuck by their plans to initiate trials mid year as stated. Does the market really know if the negotiations are for the pharma to take the drug solo and do the trials or is it for a joint licensing agreement whereby the pharma is happy for ANP to continue its plans to start trials on its timelines till negotiations are finalised and they then step in as well. Surely with the team that ANP have set up this pharma would not be happy for 1103 to be stalled in its development. Or is this deal as other Isis deals have been done whereby Isis but here ANP continue the development of the drug anyway with upfront payments and milestones and the pharma has 1st right to the drug at a later stage. Wow some here think that due to ANP initiating trials as they have always said would happen around mid year that something is wrong and the pharma has run for the hills or the offer is not great. Funny how most of them comments came after the pip drop but not straight off the bat in the morning after news. How emotions take control.

For me ANP have ticked another box and stuck to their timelines that they announced of trails for 1103 to progress. This has nothing to do with the negotiations or the offer that has been put forward but ANP moving the development of ATL1103 forward as stated. There are a number of licensing agreements that could be drawn up between the 2 parties that would still involve ANP continuing the trial process even after a deal is signed off. ANP are still in negotiations simple as that.